Antonio Serra

Showing 1-13 of 13 articles

Rotational atherectomy and the myth of Sisyphus

Serra A, Jiménez M

July 17, 2020 | 10.4244/EIJV16I4A45

Coronary interventions

Bioresorbable scaffolds versus permanent sirolimus-eluting stents in patients with ST-Segment Elevation Myocardial Infarction: vascular healing outcomes from the MAGSTEMI trial

Gomez-Lara J, Ortega-Paz L, Brugaletta S, Cuesta J, Romani S, Serra A, Salinas P, García del Blanco B, Goicolea J, Hernandez-Antolín R, Antuna P, Romaguera R, Regueiro A, Rivero F, Cequier A, Alfonso F, Gomez-Hospital J, Sabate M, Freixa X, Masotti M, Ferreiro JL, Roura G, Bastante T, Jiménez M, Otaegui I, Bordes P, Iñiguez A

April 21, 2020 | 10.4244/EIJ-D-20-00198

Coronary interventions

Bioresorbable vascular scaffolds in coronary chronic total occlusions: clinical, vasomotor and optical coherence tomography findings at three-year follow-up (ABSORB-CTO study)

Gheorghe L, Millan X, Jimenez-Kockar M, Gomez-Lara J, Arzamendi D, Danduch L, Agudelo V, Serra A

May 20, 2019 | 10.4244/EIJ-D-18-00567

STEMI

Correlates of non-target vessel-related adverse events in patients with ST-segment elevation myocardial infarction: insights from five-year follow-up of the EXAMINATION trial

Spitaleri G, Moscarella E, Brugaletta S, Pernigotti A, Ortega-Paz L, Gomez-Lara J, Cequier A, Iñiguez A, Serra A, Jimenez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Bethencourt A, Vázquez N, Valgimigli M, Serruys P, Sabate M

March 20, 2018 | 10.4244/EIJ-D-17-00608

Coronary interventions

Impact of stent overlapping on long-term clinical outcomes in patients with ST-segment elevation myocardial infarction: insights from the five-year follow-up of the EXAMINATION trial

Ortega-Paz L, Brugaletta S, Giacchi G, Ishida K, Cequier A, Iñiguez A, Serra A, Jimenez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Valgimigli M, Serruys P, Sabate M

August 4, 2017 | 10.4244/EIJ-D-16-00512

Coronary interventions

Everolimus-eluting bioresorbable vascular scaffolds for treatment of complex chronic total occlusions

Fam J, Ojeda S, Garbo R, Latib A, La Manna A, Vaquerizo B, Boukhris M, Vlachojannis G, van Geuns R, Ezhumalai B, Kawamoto H, van der Sijde J, Felix C, Pan M, Serdoz R, Boccuzzi G, De Paolis M, Sardella G, Mancone M, Tamburino C, Smits P, Di Mario C, Seth A, Serra A, Colombo A, Serruys P, Galassi A, Zijlstra F, Van Mieghem N, Diletti R

June 20, 2017 | 10.4244/EIJ-D-16-00253

Coronary interventions

Bioresorbable polymer sirolimus-eluting coronary stent compared with permanent polymer everolimus-eluting coronary stent implantation for treatment of small vessel coronary artery disease: CENTURY II trial

Wöhrle J, Markovic S, Rottbauer W, Muramatsu T, Kadota K, Vázquez-González N, Odenstedt J, Serra A, Antoniucci D, Varenne O, Saito S, Wijns W

June 10, 2016 | 10.4244/EIJV12I2A30

Five-year clinical outcome of the Nobori drug-eluting coronary stent system in the treatment of patients with coronary artery disease: final results of the NOBORI 1 trial

Chevalier B, Wijns W, Silber S, Garcia E, Serra A, Paunovic D, Serruys P

September 22, 2015 | 10.4244/EIJY14M12_13

Bioresorbable everolimus-eluting vascular scaffold for the treatment of chronic total occlusions: CTO-ABSORB pilot study

Vaquerizo B, Barros A, Pujadas S, Bajo E, Estrada D, Miranda-Guardiola F, Rigla J, Jiménez M, Cinca J, Serra A

September 22, 2015 | 10.4244/EIJY14M12_07

Predictors of adverse events among patients undergoing primary percutaneous coronary intervention: insights from a pooled analysis of the COMFORTABLE AMI and EXAMINATION trials

Taniwaki M, Stefanini G, Räber L, Brugaletta S, Cequier A, Heg D, Iñiguez A, Kelbæk H, Serra A, Ostojic M, Hernández-Antolín R, Baumbach A, Blochlinger S, Jüni P, Mainar V, Sabate M, Windecker S

August 20, 2015 | 10.4244/EIJY14M07_12

Drug-coated balloons for de novo coronary lesions: results from the Valentines II trial

Waksman R, Serra A, Loh J, Malik F, Torguson R, Stahnke S, Von Strandmann R, Rodríguez A

September 27, 2013 | 10.4244/EIJV9I5A98

Clinical performance of a drug-eluting stent with a biodegradable polymer in an unselected patient population: the NOBORI 2 study

Danzi G, Chevalier B, Urban P, Fath-Ordoubadi F, Carrié D, Wiemer M, Serra A, Wijns W, Kala P, Stabile A, Ruigomez J, Sagic D, Laanmets P, Strupp G, West N, Paunovic D

May 15, 2012 | 10.4244/EIJV8I1A17

Rationale and design of the EXAMINATION trial: a randomised comparison between everolimus-eluting stents and cobalt-chromium bare-metal stents in ST-elevation myocardial infarction

Sabate M, Cequier A, Iñiguez A, Serra A, Hernández-Antolín R, Mainar V, Valgimigli M, Tespili M, den Heijer P, Bethencourt A, Vazquez N, Brugaletta S, Backx B, Serruys P

December 30, 2011 | 10.4244/EIJV7I8A154

1

Latest news

Special issue on PCR Valves e-Course; patient-centring the Heart Team, COVID and clinical trials...

Baseline severe MR, transthoracic echocardiography

November 20, 2020

Read the LEMON study

December 1, 2020

An obituary for Professor Tony Gershlick 1951-2020

December 1, 2020

Popular Tavi-A, TAILOR-PCI, ATPCI, PORTICO-IDE and more

(Thanks to the support of Biotronik)

November 12, 2020

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

Patient preferences and Heart Team decision

November 20, 2020

This Week's JAA's: Balloon-based techniques for calcific CAD...

December 1, 2020

Valvular disease